Life ScienceCompany
Sea Lane Biotechnologies - Antibody and Protein Engineering Technology Ownership
Who owns Sea Lane Biotechnologies - Antibody and Protein Engineering Technology?
Sea Lane Biotechnologies - Antibody and Protein Engineering Technology is owned by i2 Pharmaceuticals. It was acquired on May 30, 2017.
Sea Lane Biotechnologies - Antibody and Protein Engineering Technology Business Overview
Where is Sea Lane Biotechnologies - Antibody and Protein Engineering Technology headquartered?
Sea Lane Biotechnologies - Antibody and Protein Engineering Technology is headquartered in Atherton, California.
What sector is Sea Lane Biotechnologies - Antibody and Protein Engineering Technology in?
Sea Lane Biotechnologies - Antibody and Protein Engineering Technology is a life science company.
Life Science M&A Summary in 2017
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.
Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.